Phase I trial for the Prevention of Cytokine Release Syndrome (CRS) with Cyclosporine in Patients with Moderate COVID-19
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Age: Between 18 - 99 Years
Gender: Male or Female